¼¼°èÀÇ °æÇÇÀû »ê¼Ò ³óµµ ÃøÁ¤ ½Ã½ºÅÛ ½ÃÀå
Transcutaneous Oximetry Systems
»óǰÄÚµå : 1799063
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 282 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,209,000
PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÆÄÀÏ ³» ÅØ½ºÆ®ÀÇ º¹»ç ¹× ºÙ¿©³Ö±â´Â °¡´ÉÇÏÁö¸¸, Ç¥/±×·¡ÇÁ µîÀº º¹»çÇÒ ¼ö ¾ø½À´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,629,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ¹× 100% ÀÚȸ»çÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1Àδç 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ °æÇÇÀû »ê¼Ò ³óµµ ÃøÁ¤ ½Ã½ºÅÛ ½ÃÀåÀº 2030³â±îÁö 1¾ï 8,200¸¸ ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 1¾ï 3,310¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â °æÇÇÀû »ê¼Ò ³óµµ ÃøÁ¤ ½Ã½ºÅÛ ½ÃÀåÀº 2030³â¿¡´Â 1¾ï 8,200¸¸ ´Þ·¯¿¡ À̸£°í, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 5.4%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ¸»ÃÊÇ÷°ü Àå¾Ö ¿ëµµ´Â CAGR 6.6%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á±îÁö 9,040¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ´ç´¢º´¼º Á·ºÎ±Ë¾ç ¿ëµµ ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£Áß CAGR 3.4%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 3,630¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 8.7%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ °æÇÇÀû »ê¼Ò ³óµµ ÃøÁ¤ ½Ã½ºÅÛ ½ÃÀåÀº 2024³â¿¡´Â 3,630¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2024-2030³âÀÇ ºÐ¼® ±â°£¿¡ CAGR 8.7%·Î ¼ºÀåÀ» Áö¼ÓÇÏ¿©, 2030³â±îÁö 3,690¸¸ ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 2.5%¿Í 5.4%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 3.5%¸¦ º¸ÀÏ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ °æÇÇÀû »ê¼Ò ³óµµ ÃøÁ¤ ½Ã½ºÅÛ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

°æÇÇÀû »ê¼Ò ³óµµ ÃøÁ¤ ½Ã½ºÅÛÀº ¾î¶»°Ô ÀÓ»óÀû ÆÇ´ÜÀ» À¯µµÇմϱî?

°æÇÇÀû »ê¼ÒÆ÷È­µµ ÃøÁ¤(TcPO2) ½Ã½ºÅÛÀº ¸ð¼¼Ç÷°ü¿¡¼­ È®»êµÇ´Â »ê¼Ò ³óµµ¸¦ Áö¼ÓÀûÀ¸·Î ÃøÁ¤Çϱâ À§ÇØ ÇǺο¡ ºÎÂøµÈ °¡¿­ ÇÁ·Îºê¸¦ »ç¿ëÇÕ´Ï´Ù. ÀÌ ºñħ½ÀÀû ÀåÄ¡´Â »óó Ä¡·á, ¸»Ãʵ¿¸Æ Áúȯ Æò°¡, °í¾Ð Ä¡·á, ÀÌ½ÄÆí ¸ð´ÏÅ͸µ¿¡ ÇʼöÀûÀ̸ç, ¹Ýº¹ÀûÀΠäÇ÷ ¾øÀ̵µ Á¶Á÷ °ü·ù¿¡ ´ëÇÑ ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ½Ç½Ã°£ µ¥ÀÌÅ͸¦ ÅëÇØ ÀÓ»óÀÇ´Â Ä¡·á °¡´É¼ºÀ» Æò°¡Çϰí, »ê¼Ò ¿ä¹ýÀ» Á¶Á¤Çϰí, ±Ë¾ç À§ÇèÀ» ¿¹ÃøÇÒ ¼ö ÀÖ½À´Ï´Ù.

TcPO2ÀÇ Á¤È®¼º°ú »ç¿ë ÆíÀǼºÀ» ³ôÀÌ´Â ±â¼ú Çõ½ÅÀ̶õ?

ÃֽŠTcPO2 ½Ã½ºÅÛÀº ¸î ÃÊ ¸¸¿¡ ¾ÈÁ¤È­µÇ´Â ±Þ¼Ó °¡¿­ Á¤Àü ¿ë·®½Ä ¼¾¼­¸¦ žÀçÇÏ¿© ±³Á¤ ½Ã°£À» ´ÜÃàÇÕ´Ï´Ù. ¹«¼± ºí·çÅõ½º ¿¬°áÀ» ÅëÇØ ¿ø°Ý ¸ð´ÏÅ͸µ ¹× º´¿ø Á¤º¸ ½Ã½ºÅÛ°úÀÇ ÅëÇÕÀÌ °¡´ÉÇØÁ³½À´Ï´Ù. ¼¾¼­ ÆÐµå¿¡´Â ÀÌÁ¦ ÀÏȸ¿ë Á¢Âø Çʸ§ÀÌ Æ÷ÇԵǾî ÀÖ¾î ±³Â÷ ¿À¿°À» ÁÙÀ̰í ȯÀÚ °£ À纸Á¤ÀÌ ÇÊ¿ä ¾ø´Â ÀÏȸ¿ë Á¢Âø Çʸ§ÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. °í±Þ ¾Ë°í¸®ÁòÀÌ ÁÖº¯ ¿Âµµ¿Í ÇǺΠµÎ²²¸¦ ÀÚµ¿ Á¶Á¤ÇÏ¿© ´Ù¾çÇÑ È¯ÀÚ±º¿¡ ´ëÇÑ ÃøÁ¤ Á¤È®µµ¸¦ ³ôÀÔ´Ï´Ù.

¾î¶² ÀÓ»ó ȯ°æ¿¡¼­ °æÇÇÀû »ê¼Ò ÃøÁ¤ÀÌ ÇÊ¿äÇմϱî?

»óó°ü¸®¼¾ÅÍ¿¡¼­´Â TcPO2¸¦ »ç¿ëÇÏ¿© ±Ë¾çÀÇ º´±â ¹× Ä¡À¯ °¡´É¼ºÀ» Æò°¡Çϰí Ä¡·á °­µµ¸¦ ÃÖÀûÈ­Çϱâ À§ÇØ »ç¿ëÇϰí ÀÖ½À´Ï´Ù. Ç÷°ü¿Ü°úÆÀ¿¡¼­´Â »çÁö Àç°Ç¼ú ÈÄ ÃßÀû°üÂû ½Ã TcPO2¸¦ »ç¿ëÇϰí ÀÖ½À´Ï´Ù. °í¾Ð »ê¼Ò ¿ä¹ý¿¡¼­ TcPO2´Â Ä¡·á Àü, Ä¡·á Áß, Ä¡·á ÈÄ Á¶Á÷ Æ÷È­µµ¸¦ ÃßÀûÇÏ°í ¾Ð·Â ÇÁ·ÎÅäÄÝÀ» Á¶Á¤ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¼Ò¾Æ ¹× ½Å»ý¾Æ ÁßȯÀڽǿ¡¼­´Â À§Çè¿¡ óÇÑ ¿µ¾ÆÀÇ °ü·ù¸¦ ¸ð´ÏÅ͸µÇÕ´Ï´Ù. ¸¸¼º »óó ¹× ¸»ÃÊÇ÷°üÁúȯ ȯÀÚÀÇ ÀçÅÃÄ¡·á ¼­ºñ½º Á¦°ø¾÷ü´Â ÈÞ´ë¿ë ½Ã½ºÅÛÀ» Ȱ¿ëÇÏ¿© Áø·á »çÀÌ»çÀÌ¿¡ ȯÀÚÀÇ °æ°ú¸¦ ÃßÀûÇÒ ¼ö ÀÖ½À´Ï´Ù.

TcPO2 ½Ã½ºÅÛ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº ¹«¾ùÀΰ¡?

°æÇÇÀû »ê¼ÒÆ÷È­µµ ÃøÁ¤ ½ÃÀåÀÇ ¼ºÀå ¿øµ¿·ÂÀº ¸¸¼º »óó(ƯÈ÷ ´ç´¢º´¼º Á·ºÎ ±Ë¾ç)ÀÇ ¹ß»ý·ü Áõ°¡, »çÁö ±¸È£ Àü·«ÀÇ Á߿伺, ºñħ½ÀÀû Áø´Ü µµ±¸ÀÇ Ã¤Åà Áõ°¡ µîÀÔ´Ï´Ù. ÀÓ»ó °¡À̵å¶óÀο¡¼­´Â Ç÷°ü °ü·Ã ÀÇ»ç°áÁ¤À» À§ÇØ °ü·ù ÃøÁ¤À» ÁöÁöÇϰí ÀÖ½À´Ï´Ù. ±â¼úÀÇ ¼ÒÇüÈ­¿Í ¹«¼± ±â´ÉÀº ¿Ü·¡ Áø·áÀÇ ÅëÇÕÀ» ÃËÁøÇÕ´Ï´Ù. ºñ¿ë È¿°ú ºÐ¼®¿¡ µû¸£¸é, Àý´Ü ¹× ÀÔ¿ø ±â°£ ´ÜÃàÀ» º¸¿© ÁÖ¸ç, 1Â÷ ¹× Àü¹® Áø·á ȯ°æ¿¡¼­ Æø³Ð°Ô »ç¿ëÇϵµ·Ï ±ÇÀåÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

¿ëµµ(¸»ÃÊÇ÷°ü Àå¾Ö ¿ëµµ, ´ç´¢º´¼º Á·ºÎ±Ë¾ç ¿ëµµ, Á¶»ê ¿ëµµ, ±âŸ ¿ëµµ), ÃÖÁ¾»ç¿ëÀÚ(º´¿ø ÃÖÁ¾»ç¿ëÀÚ, Áø·á¼Ò ÃÖÁ¾»ç¿ëÀÚ, ±âŸ ÃÖÁ¾»ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ¼­, ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°èº° SLM Äõ¸®¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ´ë·® ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Transcutaneous Oximetry Systems Market to Reach US$182.0 Million by 2030

The global market for Transcutaneous Oximetry Systems estimated at US$133.1 Million in the year 2024, is expected to reach US$182.0 Million by 2030, growing at a CAGR of 5.4% over the analysis period 2024-2030. Peripheral Vascular Disorders Application, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$90.4 Million by the end of the analysis period. Growth in the Diabetic Foot Ulcers Application segment is estimated at 3.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$36.3 Million While China is Forecast to Grow at 8.7% CAGR

The Transcutaneous Oximetry Systems market in the U.S. is estimated at US$36.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$36.9 Million by the year 2030 trailing a CAGR of 8.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.5% and 5.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.

Global Transcutaneous Oximetry Systems Market - Key Trends & Drivers Summarized

How Do Transcutaneous Oximetry Systems Guide Clinical Decisions?

Transcutaneous oximetry (TcPO2) systems employ heated probes adhered to the skin to continuously measure oxygen tension diffusing from capillaries. These non-invasive devices are essential in wound care, peripheral artery disease assessments, hyperbaric therapy, and graft monitoring, providing insights into tissue perfusion without repeated blood draws. Such real-time data allows clinicians to evaluate healing potential, adjust oxygen therapy, and predict ulcer risk-especially in diabetic or vascular-compromised patients.

What Innovations Elevate TcPO2's Accuracy and Usability?

Modern TcPO2 systems feature rapid-heating capacitive sensors that stabilize within seconds, reducing calibration time. Wireless Bluetooth connectivity enables remote monitoring and integration with hospital information systems. Sensor pads now include disposable adhesive membranes that reduce cross-contamination and eliminate recalibration between patients. Advanced algorithms auto-adjust for ambient temperature and skin thickness, enhancing measurement precision across diverse patient populations.

Which Clinical Environments Depend on Transcutaneous Oxygen Measurement?

Wound management centers rely on TcPO2 to stage ulcers and assess the likelihood of healing, optimizing treatment intensity. Vascular surgery teams use it during limb revascularization follow-up. In hyperbaric oxygen therapy, TcPO2 tracks tissue saturation before, during, and after treatments-helping tailor pressure protocols. Pediatric and neonatal ICUs monitor perfusion in at-risk infants. Home-care providers for chronic wounds or peripheral vascular disease patients leverage portable systems to track progress between clinical visits.

What Is Powering TcPO2 Systems’ Market Growth?

The growth in the transcutaneous oximetry market is driven by rising chronic wound incidence-particularly diabetic foot ulcers-greater emphasis on limb salvage strategies, and increasing adoption of non-invasive diagnostic tools. Clinical guidelines support perfusion measurement for vascular decision-making. Technological miniaturization and wireless capabilities enhance ambulatory care integration. Cost-efficiency analyses illustrate reduced amputations and hospital stays, encouraging broader reimbursement adoption in primary and specialist settings.

SCOPE OF STUDY:

The report analyzes the Transcutaneous Oximetry Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Peripheral Vascular Disorders Application, Diabetic Foot Ulcers Application, Preterm Births Application, Other Applications); End-User (Hospitals End-User, Clinics End-User, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â